Background & Aims We conducted a systematic review with meta-analysis to estimate rates
and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re …

The therapeutic management of older patients with inflammatory bowel disease (IBD) is
challenging, particularly because of the absence of evidence-based guidelines for these …

Canada has among the highest incidence and prevalence of inflammatory bowel disease
(IBD) in the world. After decades of rising incidence of IBD in Canada during the 20th …

Background & Aims Diagnosis of inflammatory bowel diseases (IBD) is increasing among
elderly persons (60 years or older). We performed a nationwide population-based study to …

Background & Aims Infections are an important adverse effect of immunosuppression for
treatment of inflammatory bowel diseases (IBDs). However, risk of infection cannot be …

Background Several studies have shown that neurodegenerative diseases (eg, Parkinson's
disease [PD] and Alzheimer's disease [AD]) are associated with inflammatory bowel disease …

Direct health care costs of illness reflect the costs of medically necessary services and
treatments paid for by public and private payers, including hospital-based care, outpatient …

Objectives To examine all-cause and cause-specific mortality in adult-onset and elderly-
onset IBD and to describe time trends in mortality over the past 50 years. Design Swedish …

Inflammatory bowel diseases (IBD), consisting of Crohn's disease and ulcerative colitis, are
chronic remitting, relapsing inflammatory conditions of the gastrointestinal tract. While …

Background The prevalence of older adults with inflammatory bowel diseases (IBD) is
increasing. Frailty is an important predictor of outcomes in many chronic disease states. The …